PRL3-zumab, a first-in-class humanized antibody for cancer therapy. - Wikidata - awgldk - TriplyDB

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

http://www.wikidata.org/entity/Q37277211

about

Therapeutic Antibodies against Intracellular Tumor Antigens Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.New Approaches to Difficult Drug Targets: The Phosphatase Story Chemotherapy induced PRL3 expression promotes cancer growth via plasma membrane remodeling and specific alterations of caveolae-associated signaling

P2860

Q41462883-A0ECC474-9CC1-435C-BF71-F7003A4E2C1D Q47123783-9720ABE6-645A-410C-8980-B05B6497E203 Q47881716-DC6B3589-BC29-45B8-BB39-8E1E6E3F6A9A Q47956417-509FE0C6-4D65-4B48-97B5-99108454F939 Q48103763-0B9DB620-66CE-40E5-AA29-D72FC7A78FC9 Q56513340-B7A0552B-FF98-49EB-B131-853BDF1A2CF1 Q58694966-481E1E04-9306-4416-BC20-1FC78D700DE5

P2860

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

http://www.wikidata.org/entity/Q37277211

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

@en

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

@nl

type

label

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

@en

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

@nl

prefLabel

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

@en

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

@nl

P1433

Q37277211-52FC7D1B-C2C8-4464-B85F-EFAD4CB774E0

P1476

Q37277211-8A40C671-CFA5-458B-9ABD-9F37B9680C01

P2093

Q37277211-0DB198DD-80B5-4C33-B2CC-0A03482B8B6F

Q37277211-10529EBB-ED7E-486C-8A4C-BF447A635789

Q37277211-1C22567A-7DA4-4D3B-BC6D-A72155F1C90D

Q37277211-1C7A7E1A-D50E-4FF4-83B0-9B303B1F5DF8

Q37277211-5C5B1BB2-C65A-4C3B-9D1D-4B58BD029000

Q37277211-5DFE27E5-AAC6-44D3-B2A2-C924AB2C26E3

Q37277211-61ACE1E0-17FE-4A64-AEDA-57A6059D00DD

Q37277211-6B108491-0A26-4E92-B1F2-516BB275A9C3

Q37277211-731E0D61-7214-4947-B5EB-91714AB63D8B

Q37277211-777C49AD-DDA1-47AA-9DBB-C2E33BD48BDB

P2860

Q37277211-0CBCF865-A947-4C4C-8484-AD7FB766C3EF

Q37277211-1E2A157A-EF4B-489E-88FA-F93640EA318C

Q37277211-2027DD31-DF50-414E-901B-46955CCBAAA0

Q37277211-22B2BCA8-C82C-4CF5-A9E8-688ADBFB185D

Q37277211-2BDB1256-3913-4F45-A48A-A4AA835B6980

Q37277211-384BCF19-9970-4910-ACC2-17F261976364

Q37277211-3877EB05-F100-4F15-A5EA-A39E69D10E09

Q37277211-3B5456BB-82D9-4DE4-91B0-014F1C48E4E1

Q37277211-3E6CE109-424E-44DB-864C-70E54F0D08D3

Q37277211-3FBAFA79-046E-4D9A-95FD-E168B0D9C504

P304

Q37277211-0E2C264E-C6F5-4FF1-8D1C-7AA18FB75FBF

P31

Q37277211-BA38B639-26FC-4FA3-A0A6-F0001A59F865

P356

Q37277211-21A309DB-8C38-45C2-A6EA-30C703B0AE5C

P433

Q37277211-3D293BA9-6796-4440-AA59-9934D8A1F98D

P478

Q37277211-3DAF0BC2-4FEC-439A-8042-4DD96E0AA951

P50

Q37277211-9718038A-4B41-483B-A337-3F5DCEF94E3F

Q37277211-F1053734-5A30-4B57-A325-3B60B6346302

P577

Q37277211-71B5699A-6572-4D2C-8E9E-61447A92795E

P698

Q37277211-826CF9D3-5466-4C3B-8928-071DEEC01DF1

P932

Q37277211-2A57D53E-4BA2-405F-AE44-8542EED98EFB

P356

JCI.INSIGHT.87607

P1433

P1476

PRL3-zumab, a first-in-class humanized antibody for cancer therapy

@en

P2093

Abdul Qader Omer Al-Aidaroos

http://www.w3.org/2001/XMLSchema#string

Abhishek Gupta

http://www.w3.org/2001/XMLSchema#string

Boon Cher Goh

http://www.w3.org/2001/XMLSchema#string

Cheng William Hong

http://www.w3.org/2001/XMLSchema#string

Elya Chen

http://www.w3.org/2001/XMLSchema#string

Hiu Fung Yuen

http://www.w3.org/2001/XMLSchema#string

Hyun Cheol Chung

http://www.w3.org/2001/XMLSchema#string

Jean Paul Thiery

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Koji Kono

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of cellular metabolism by protein lysine acetylation

Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.

Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1

A humanized antibody that binds to the interleukin 2 receptor

Treatment of gastric cancer

Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome

A phosphatase associated with metastasis of colorectal cancer

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

P304

e87607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI.INSIGHT.87607

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27699276

http://www.w3.org/2001/XMLSchema#string

P932

5033845

http://www.w3.org/2001/XMLSchema#string